News
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...
SP-26 is a ketamine-based injectable dissolvable polymer implant for chronic pain and fibromyalgia. If clinically successful, SP-26 could qualify for the FDA's streamlined 505(b)(2) regulatory ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...
DOVER, Del.--(BUSINESS WIRE)--Telehealth company Henry Meds, known for its innovation in telehealth medicine and commitment to patient-centric care, announced today that it will now provide ...
A team of researchers at the University of Reading created an easily dissolvable adhesive that could lead to cleaner and more effective plastic recycling. It's common for adhesives used to attach ...
New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase III clinical ...
That came in response to a February lawsuit from a compounding trade group against the Food and Drug Administration's determination that the active ingredient in those drugs, semaglutide ...
A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results